Menz Bradley D, Charani Esmita, Gordon David L, Leather Andrew J M, Moonesinghe S Ramani, Phillips Cameron J
SA Pharmacy, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.
Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Infect Drug Resist. 2021 Dec 7;14:5235-5252. doi: 10.2147/IDR.S319780. eCollection 2021.
The increasing incidence of antimicrobial resistance (AMR) presents a global crisis to healthcare, with longstanding antimicrobial agents becoming less effective at treating and preventing infection. In the surgical setting, antibiotic prophylaxis has long been established as routine standard of care to prevent surgical site infection (SSI), which remains one of the most common hospital-acquired infections. The growing incidence of AMR increases the risk of SSI complicated with resistant bacteria, resulting in poorer surgical outcomes (prolonged hospitalisation, extended durations of antibiotic therapy, higher rates of surgical revision and mortality). Despite these increasing challenges, more data are required on approaches at the institutional and patient level to optimise surgical antibiotic prophylaxis in the era of antibiotic resistance (AR). This review provides an overview of the common resistant bacteria encountered in the surgical setting and covers wider considerations for practice to optimise surgical antibiotic prophylaxis in the perioperative setting.
抗菌药物耐药性(AMR)的发病率不断上升,给医疗保健带来了全球性危机,长期使用的抗菌药物在治疗和预防感染方面的效果越来越差。在外科手术环境中,长期以来,抗生素预防一直是预防手术部位感染(SSI)的常规标准治疗方法,而手术部位感染仍然是最常见的医院获得性感染之一。AMR发病率的不断上升增加了SSI合并耐药菌的风险,导致手术结果更差(住院时间延长、抗生素治疗时间延长、手术翻修率和死亡率更高)。尽管面临这些日益严峻的挑战,但在抗生素耐药性(AR)时代,仍需要更多关于机构和患者层面优化手术抗生素预防方法的数据。本综述概述了外科手术环境中常见的耐药菌,并涵盖了在围手术期优化手术抗生素预防措施的更广泛实践考虑因素。